Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sonoma Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sonoma Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Weigerstorfer Philippe | Director | – | Jul 9, 2026 | 2 |
| Trombly Amy Moss | Chief Executive Officer | 153,586 | Jul 9, 2026 | 2 |
| McLaughlin John | Director | – | Jul 9, 2026 | 2 |
| Jacoby Vanessa | Director | – | Jul 9, 2026 | 1 |
| Dvonch Jerome J | Chief Financial Officer | 84,595 | Jul 9, 2026 | 2 |
| Dal Poggetto John | Controller | 15,000 | Jul 9, 2026 | 2 |
| Birnbaum Jay E | Director | – | Jan 2, 2026 | 1 |
| Thornton Bruce | Executive VP and COO | 154,411 | Jun 20, 2025 | 0 |
| White Chad Norman | Chief Financial Officer | – | Dec 30, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.